No consumer adhesive GLP-1 patch has demonstrated systemic delivery in peer-reviewed human trials, and they do not replicate the tested mechanisms or outcomes of prescription therapies
Its interest stems from pre-clinical research showing tissue-repair, anti-inflammatory, cytoprotective and angiogenic effects in animal models
Semaglutide pharmacology & regulatory considerations
These include: Neurodegenerative diseases: Conditions such as Parkinson's and Alzheimer's disease involve protein misfolding and chronic inflammation
LegitScript certified, verifiable US address, and publicly listed pharmacy partners are all positives
Jacobsen LV, Vouis J, Hindsberger C, Zdravkovic M